Medac Pharma, Inc., a privately held, commercial-stage specialty pharmaceutical company, announced today the appointment of industry veteran Kevin O'Brien as Vice President of Sales for the company. In this role, Mr. O'Brien will lead all sales and sales training activities for the promotion of Rasuvo® (methotrexate) injection, Medac Pharma's first commercialized product in the U.S.